Skip to content

Clinical outcomes of ACL reconstruction using LARS artificial graft with average 10-year follow-up

Clinical outcomes of ACL reconstruction using LARS artificial graft with average 10-year follow-up

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017296
Enrollment
Unknown
Registered
2018-07-23
Start date
2004-01-01
Completion date
Unknown
Last updated
2018-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anterior cruciate ligament injury

Interventions

anterior cruciate ligament reconstruction group:LARS reconstruction

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Unlimited age; 2. single ACL injury (for cases of combined medial collateral ligament (MCL) injury, if no surgical intervention was performed on MCL, the study was included); 3. first ACL reconstruction surgery; 4. Repair of meniscus or cartilage damage at the same time. 5. no previous history of knee surgery; 6. No follow-up visits were lost for 10 years or more

Exclusion criteria

Exclusion criteria: 1. A CL revision; 2. more than 2 degrees of cartilage damage (Outerbridge type); 3. or multiple ligament damage; 4. Joint degeneration greater than or equal to III (KELLGREN&LAWRENCE classification); 5. bilateral knee trauma; 6. multiple ligament damage (with MCL injury, surgical intervention is required, as described in "inclusion")

Design outcomes

Primary

MeasureTime frame
Complication;

Countries

China

Contacts

Public ContactNing Hu

The First Affiliated Hospital of Chongqing Medical University

HuNjoint@yahoo.com+86 18696761022

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026